Measurement and characterization of membrane-bound and soluble epoxide hydrolase activities in resting mononuclear leukocytes from human blood.
نویسندگان
چکیده
Membrane-bound and soluble epoxide hydrolase activities in the mononuclear cell fraction from human blood have been characterized using cis- and trans-stilbene oxides as substrates, respectively. Because of the low activities in these cells, it was necessary to modify assay procedures developed for rat and mouse liver in the following ways: (a) the substrates were relatively highly labeled (2 Ci/mmol) and carefully purified; (b) the incubation time was extended to 45 to 60 min, during which period the activities were linear; (c) as many as 6 million cells were used for a single assay, which was also within the linear range of the procedure. The membrane-bound epoxide hydrolase characterized in this manner has an apparent Vmax of 7.26 pmol product formed per min per 10(7) cells and an apparent Km of 9.96 microM. The pH optimum was observed to be around 9.8. The dependence of this activity on temperature showed its optimum at 40 degrees. The soluble epoxide hydrolase activity has an apparent Vmax of about 8.26 pmol product formed per min per 10(7) cells, an apparent Km of 1.63 microM, a pH optimum of 6.2 to 6.8, and a temperature optimum at 60 degrees. Using these techniques, these activities have also been determined in other blood components, i.e., lymphocytes, monocytes, granulocytes, erythrocytes, platelets, and plasma. Lymphocytes account for most of the epoxide hydrolase activity towards cis-stilbene oxide, and all of the activity towards trans-stilbene oxide is in the human mononuclear cell fractions. Different substances known to affect rodent epoxide hydrolases were tested for their effects on the human mononuclear blood cell activities. Interestingly, 1,1,1-trichloropropane 2,3-epoxide, a potent inhibitor of liver microsomal epoxide hydrolase in different species including rat, mouse, and human, had little or no effect on the membrane-bound activity measured here. However, cyclohexene oxide inhibits this membrane-bound activity 60%. The soluble epoxide hydrolase is inhibited to 90% of control levels by chalcone epoxide. The membrane-bound and soluble epoxide hydrolase activities determined in 27 subjects varied from 8.2 to 18.5 and from 3.5 to 17.0 pmol product formed per min per 10(7) cells, respectively. The mean coefficient of intraindividual variation, determined with three subjects measured four times each over the course of 18 days, was approximately 10% for both enzyme activities.
منابع مشابه
Enhancement of Soluble Expression and Biochemical Characterization of Two Epoxide Hydrolases from Bacillus
Background: Enantiopure epoxides are important intermediates in the synthesis of high-value chiral chemicals. Epoxide hydrolases have been exploited in biocatalysis for kinetic resolution of racemic epoxides to produce enantiopure epoxides and vicinal diols. It is necessary to obtain sufficient stable epoxide hydrolases with high enantioselectivity to meet the requirements of i...
متن کاملDesign, Synthesis and Biological Activity of 4,6-disubstituted Pyridin-2(1H)-ones as Novel Inhibitors of Soluble Epoxide Hydrolase
Soluble epoxide hydrolase enzyme is a promising therapeutic target for hypertension, vascular inflammation, pain and some other risk factors of cardiovascular diseases. The most potent sEH inhibitors reported in the literature are urea-based ones which often have poor bioavailability. In this study, in a quest for finding potent inhibitors of soluble epoxide hydrolase, some 4,6-disubstituted py...
متن کاملDesign, Synthesis and Biological Activity of 4,6-disubstituted Pyridin-2(1H)-ones as Novel Inhibitors of Soluble Epoxide Hydrolase
Soluble epoxide hydrolase enzyme is a promising therapeutic target for hypertension, vascular inflammation, pain and some other risk factors of cardiovascular diseases. The most potent sEH inhibitors reported in the literature are urea-based ones which often have poor bioavailability. In this study, in a quest for finding potent inhibitors of soluble epoxide hydrolase, some 4,6-disubstituted py...
متن کاملDesign, Synthesis and Biological Evaluation of 4-Benzamidobenzoic Acid Hydrazide Derivatives as Novel Soluble Epoxide Hydrolase Inhibitors
Inhibitors of soluble epoxide hydrolase (sEH) represent one of the novel pharmaceutical approaches for treating hypertension, vascular inflammation, pain and other cardiovascular related diseases. Most of the potent sEH inhibitors reported in literature often suffer from poor solubility and bioavailability. Toward improving pharmacokinetic profile beside favorable potency, two series of 4-benza...
متن کاملDesign, Synthesis and Biological Evaluation of 4-Benzamidobenzoic Acid Hydrazide Derivatives as Novel Soluble Epoxide Hydrolase Inhibitors
Inhibitors of soluble epoxide hydrolase (sEH) represent one of the novel pharmaceutical approaches for treating hypertension, vascular inflammation, pain and other cardiovascular related diseases. Most of the potent sEH inhibitors reported in literature often suffer from poor solubility and bioavailability. Toward improving pharmacokinetic profile beside favorable potency, two series of 4-benza...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Cancer research
دوره 44 9 شماره
صفحات -
تاریخ انتشار 1984